Effect of chemical modification on insulin stability: A Comprehensive Review

سال انتشار: 1404
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 70

متن کامل این مقاله منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل مقاله (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

ZISTCONF05_074

تاریخ نمایه سازی: 13 مرداد 1404

چکیده مقاله:

Insulin is an essential peptide hormone produced by the beta cells of the pancreas that plays a central role in regulating blood glucose levels. Insulin exerts its effects by binding to the insulin receptor. It is a critical therapeutic agent in diabetes management. Insulin, as a therapeutic hormone, undergoes various chemical modifications during its industrial production, pharmaceutical formulation, and even during its endogenous storage in pancreatic B-cells. These modifications can occur either randomly due to environmental stresses or deliberately through well-planned strategies to enhance insulin's pharmaceutical properties such as stability, solubility, and pharmacokinetics. Insulin is highly sensitive to environmental factors and can undergo structural changes including unfolding and aggregation, which may significantly impact its biological efficacy and pharmacological activity. Insulin analogs are specially engineered forms of insulin designed to enhance certain therapeutic properties while maintaining the fundamental biological activity of native insulin. these engineered changes preserve insulin's molecular pharmacology meaning insulin analogs retain the ability to bind to the insulin receptor and activate the signaling pathways necessary for glucose uptake and metabolism. This balance of improved pharmaceutical properties with preserved biological function makes insulin analogs vital tools in effective diabetes management. Understanding and controlling these chemical modifications are crucial for optimizing insulin's therapeutic performance and ensuring its safety and efficacy in diabetes treatment. The project focused on effects of chemical modifications and nanoparticles on the structure, stability, aggregation and their results in effective drug delivery system, biological activity, and pharmacological properties of insulin. The future challenge in biotechnology and pharmacokinetic arises from the complexity of biopharmaceuticals, which are often molecular structures that require formulation and delivery strategies to ensure their efficacy and safety.

نویسندگان

Reyhane Kamelnia

Department of Clinical Sciences, Faculty of Veterinary Medicine, Semnan University, Semnan, Iran.

Mahmood Ahmadi-hamedani

Department of Clinical Sciences, Faculty of Veterinary Medicine, Semnan University, Semnan, Iran.

Elahe Kamelnia

Department of biology, Faculty of sciences, Mashhad branch, Islamic Azad University, Mashhad, Iran

Majid Darroudid

Department of Basic Medical Sciences, Mashhad University of Medical Sciences, Mashhad, Iran.